LYON Sud - Centre Hospitalier
Welcome,         Profile    Billing    Logout  
 0 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HEIBLIG, Maël
SELECT-AML-1, NCT04905407 / 2021-003910-38: Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Terminated
2
66
Europe, US
Tamibarotene, Venetoclax, Venclexta, Azacitidine, Vidaza
Syros Pharmaceuticals, Syros Pharmaceuticals, Inc.
Acute Myeloid Leukemia
08/24
08/24
AVENHIR, NCT05768711: Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia

Recruiting
2
44
Europe
Venetoclax, ABT-199
Groupe Francophone des Myelodysplasies, AbbVie
Chronic Myeloid Leukemia
02/26
10/28
AGORA-1, NCT05199051 / 2021-001813-35: A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/refractory (R/R) AML

Recruiting
2
50
Europe
Gemtuzumab ozogamicine - Cytarabine - Gilteritinib, Mylotarg - Aracytine - Xospata
Centre Antoine Lacassagne, Acute Leukemia French Association, Astellas Pharma Inc, Pfizer
AML
03/27
03/27
ODYSSEY, NCT05601726: First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Recruiting
1/2
36
Europe
ABD-3001, DIMATE
Advanced BioDesign
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes
06/26
12/26
IMGN632-0802, NCT04086264: IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Active, not recruiting
1/2
218
Europe, US
Azacitidine, Vidaza, Decitabine, IMGN632, CD123-targeted ADC, Venetoclax, Venclexta, Venclyxto
AbbVie, Jazz Pharmaceuticals
Acute Myeloid Leukemia
02/27
02/27
NCT05181735: Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

Recruiting
1/2
150
Europe
Luspatercept Injection [Reblozyl], ACE-536, Eprex, Epoietin alfa
Groupe Francophone des Myelodysplasies, Celgene
MDS, Myelodysplastic Syndromes
12/28
06/29
ALFAPPP, NCT04777916: Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Recruiting
N/A
2500
Europe
Acute Leukemia French Association
Acute Myeloid Leukemia (AML)
04/32
04/46
MTSA, NCT03439371: Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Recruiting
N/A
21
Europe
HLA-mismatched micro-transplantation after induction chemotherapy
Centre Hospitalier Universitaire de Saint Etienne, Institut de Cancérologie de la Loire
Acute Myeloid Leukemia
12/25
12/27
BMP-MDS, NCT06175923: Role of BMP Pathway in MDS Progression

Not yet recruiting
N/A
60
Europe
Collection of EDTA (disodium salt of ethylenediaminetetraacetic acid) tubes of marrow during routine care
Hospices Civils de Lyon
Myelodysplastic Syndromes, Acute Myelogenous Leukemia
01/29
01/34
MEXIRON, NCT06781099: Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis

Not yet recruiting
N/A
13
Europe
Low-volume continuous veno-venous haemodialysis with MEX-CD1 use
Hospices Civils de Lyon, MEXBrain 13 avenue Albert Einstein 69100 Villeurbanne
Myelodysplastic Syndrome, Myelofibrosis
07/26
10/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HEIBLIG, Maël
SELECT-AML-1, NCT04905407 / 2021-003910-38: Tamibarotene Plus Venetoclax/Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Terminated
2
66
Europe, US
Tamibarotene, Venetoclax, Venclexta, Azacitidine, Vidaza
Syros Pharmaceuticals, Syros Pharmaceuticals, Inc.
Acute Myeloid Leukemia
08/24
08/24
AVENHIR, NCT05768711: Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia

Recruiting
2
44
Europe
Venetoclax, ABT-199
Groupe Francophone des Myelodysplasies, AbbVie
Chronic Myeloid Leukemia
02/26
10/28
AGORA-1, NCT05199051 / 2021-001813-35: A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults with FLT3-ITD Relapse/refractory (R/R) AML

Recruiting
2
50
Europe
Gemtuzumab ozogamicine - Cytarabine - Gilteritinib, Mylotarg - Aracytine - Xospata
Centre Antoine Lacassagne, Acute Leukemia French Association, Astellas Pharma Inc, Pfizer
AML
03/27
03/27
ODYSSEY, NCT05601726: First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Recruiting
1/2
36
Europe
ABD-3001, DIMATE
Advanced BioDesign
Acute Myeloid Leukemia, Adult, Myelodysplastic Syndromes
06/26
12/26
IMGN632-0802, NCT04086264: IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid Leukemia

Active, not recruiting
1/2
218
Europe, US
Azacitidine, Vidaza, Decitabine, IMGN632, CD123-targeted ADC, Venetoclax, Venclexta, Venclyxto
AbbVie, Jazz Pharmaceuticals
Acute Myeloid Leukemia
02/27
02/27
NCT05181735: Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

Recruiting
1/2
150
Europe
Luspatercept Injection [Reblozyl], ACE-536, Eprex, Epoietin alfa
Groupe Francophone des Myelodysplasies, Celgene
MDS, Myelodysplastic Syndromes
12/28
06/29
ALFAPPP, NCT04777916: Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)

Recruiting
N/A
2500
Europe
Acute Leukemia French Association
Acute Myeloid Leukemia (AML)
04/32
04/46
MTSA, NCT03439371: Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia

Recruiting
N/A
21
Europe
HLA-mismatched micro-transplantation after induction chemotherapy
Centre Hospitalier Universitaire de Saint Etienne, Institut de Cancérologie de la Loire
Acute Myeloid Leukemia
12/25
12/27
BMP-MDS, NCT06175923: Role of BMP Pathway in MDS Progression

Not yet recruiting
N/A
60
Europe
Collection of EDTA (disodium salt of ethylenediaminetetraacetic acid) tubes of marrow during routine care
Hospices Civils de Lyon
Myelodysplastic Syndromes, Acute Myelogenous Leukemia
01/29
01/34
MEXIRON, NCT06781099: Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis

Not yet recruiting
N/A
13
Europe
Low-volume continuous veno-venous haemodialysis with MEX-CD1 use
Hospices Civils de Lyon, MEXBrain 13 avenue Albert Einstein 69100 Villeurbanne
Myelodysplastic Syndrome, Myelofibrosis
07/26
10/26

Download Options